Ramsay Générale de Santé SA (EPA: GDS)

Ramsay Générale de Santé Statistics

Total Valuation

Ramsay Générale de Santé has a market cap or net worth of EUR 1.27 billion. The enterprise value is 4.98 billion.

Market Cap	1.27B
Enterprise Value	4.98B

Important Dates

The next estimated earnings date is Friday, November 29, 2024.

Earnings Date	Nov 29, 2024
Ex-Dividend Date	n/a

Share Statistics

Ramsay Générale de Santé has 110.37 million shares outstanding. The number of shares has increased by 0.00% in one year.

Current Share Class	n/a
Shares Outstanding	110.37M
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	+11.14%
Owned by Insiders (%)	0.74%
Owned by Institutions (%)	n/a
Float	863,776

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.25
PB Ratio	1.07
P/TBV Ratio	n/a
P/FCF Ratio	3.05
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.27, with an EV/FCF ratio of 11.91.

EV / Earnings	-92.42
EV / Sales	0.99
EV / EBITDA	8.27
EV / EBIT	26.80
EV / FCF	11.91

Financial Position

The company has a current ratio of 0.87, with a Debt / Equity ratio of 3.28.

Current Ratio	0.87
Quick Ratio	0.62
Debt / Equity	3.28
Debt / EBITDA	6.69
Debt / FCF	9.63
Interest Coverage	0.93

Financial Efficiency

Return on equity (ROE) is -2.93% and return on invested capital (ROIC) is 2.19%.

Return on Equity (ROE)	-2.93%
Return on Assets (ROA)	1.68%
Return on Capital (ROIC)	2.19%
Revenue Per Employee	146,312
Profits Per Employee	-1,575
Employee Count	38,000
Asset Turnover	0.72
Inventory Turnover	29.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.59% in the last 52 weeks. The beta is 0.19, so Ramsay Générale de Santé's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	-40.59%
50-Day Moving Average	12.96
200-Day Moving Average	14.57
Relative Strength Index (RSI)	31.12
Average Volume (20 Days)	455

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ramsay Générale de Santé had revenue of EUR 5.01 billion and -53.90 million in losses. Loss per share was -0.49.

Revenue	5.01B
Gross Profit	1.37B
Operating Income	185.90M
Pretax Income	-40.80M
Net Income	-53.90M
EBITDA	356.60M
EBIT	185.90M
Loss Per Share	-0.49

Balance Sheet

The company has 359.00 million in cash and 4.03 billion in debt, giving a net cash position of -3.67 billion or -33.26 per share.

Cash & Cash Equivalents	359.00M
Total Debt	4.03B
Net Cash	-3.67B
Net Cash Per Share	-33.26
Equity (Book Value)	1.23B
Book Value Per Share	10.82
Working Capital	-219.40M

Cash Flow

In the last 12 months, operating cash flow was 586.80 million and capital expenditures -168.50 million, giving a free cash flow of 418.30 million.

Operating Cash Flow	586.80M
Capital Expenditures	-168.50M
Free Cash Flow	418.30M
FCF Per Share	3.79

Margins

Gross margin is 27.40%, with operating and profit margins of 3.71% and -1.08%.

Gross Margin	27.40%
Operating Margin	3.71%
Pretax Margin	-0.81%
Profit Margin	-1.08%
EBITDA Margin	7.12%
EBIT Margin	3.71%
FCF Margin	8.36%

Dividends & Yields

Ramsay Générale de Santé does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.00%
Shareholder Yield	-0.00%
Earnings Yield	-4.24%
FCF Yield	32.81%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Ramsay Générale de Santé has an Altman Z-Score of 0.98. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.98
Piotroski F-Score	n/a